alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
MARYLAND DEPARTMENT OF THE ENVIRONMENT 

1800 Washington Boulevard -Baltimore MD 21230 

MDE 410-537-3000 - 1-800-633-6101 

Martin O'Malley Shari T. Wilson 

Governor Secretary 

Anthony G. Brown Robert M. Summers, Ph.D. 

Lieutenant Governor Deputy Secretary 

April 22, 2009 


Mr. Shawn M. Garvin 


Regional Administrator (3RAOO) 


U.S. Environmental Protection Agency 

Region III 

1650 Arch Street 

Philadelphia PA 19103-2029 

Dear Mr. Garvin: 

The purpose of this letter is to submit the enclosed State Implementation Plan (SIP) Revision 

# 10-06 concerning Maryland's repeal the general emission standard for adhesives under 

COMAR 26.11 .19.15C(4) and replacing it with the source-specific VOC Reasonably Available 

Control Technology (RACT) emission limitation for the application of adhesives and sealants to 

specialty electronic systems and subsystems for defense and homeland security. This SIP 

Revision includes amendments to Regulation .15A and C under COMAR 26.11.19 Volatile 

Organic Compounds from Specific Processes. 

The Notice of Proposed Action for this SIP Revision was publ ished in the Maryland Register on 

December 18, 2009. A public hearing was held on January 21 , 2010. The action was adopted 

on March 21 , 2010. The Notice of Final Action was published on April 9, 2010 and the 

amendments became effective on April 19, 2010. All administrative procedures were properly 

followed throughout the adoption process. 

If you have any questions concerning this SIP submittal, please feel free to call me at (410) 537­

3084 or Mr. George (Tad) S. Aburn, Jr. , Director of the Air and Radiation Management 

Administration, at (410) 537-3255. 

Shari T. Wilson 

Secretary 

S1W:dhr 

Enclosures 

R ! dB TTy I [ ! WW ] 7 - 72 -Y 

Via Maryland Relay Service
50506.

#### HILL v. THE STATE.

Submitted April 9, 1975

Decided April 18, 1975.

*Westmoreland, Patterson & Moseley, R. Robider Markwalter,*for appellant.

*Fred M. Hasty, District Attorney, Walker P. Johnson, Assistant District Attorney,*for appellee.

Deen, Presiding Judge.

1. The defendant was indicted for murder and convicted of voluntary manslaughter. Evidence of a continued quarrel: That the deceased had hit the defendant, the defendant had cursed and ejected him, the deceased again attempted to enter the house, the defendant procured a knife, and stabbed him, causing his death, posed a jury question as to whether the killing was unjustified, in the heat of passion, and lacking in malice. Cf. *Banks v. State,*227 Ga. 578 (182 SE2d 106).

2. Nor did the court err in failing to charge the lesser offense of involuntary manslaughter. A knife, capable of and used in a manner to produce death is a deadly weapon, and when it is so used in a heat of passion and death ensues, the crime is voluntary manslaughter and failure to charge the lesser offense is not error. *Harris v. State,*75 Ga. App. 199 (2) (43 SE2d 110).

*Judgment affirmed.*

*Evans and Stolz, JJ., concur.*
EXHIBIT
      32.2





CERTIFICATION
      PURSUANT TO


18
      U.S.C.
      SECTION 1350,


AS
      ADOPTED PURSUANT TO


SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002





In
      connection with the Annual Report on Form 10-K of Main Street Restaurant Group,
      Inc. (the "Company") for the year ended December 26, 2005, as filed with the
      Securities and Exchange Commission on the date hereof (the "Report"), I, Michael
      Garnreiter, Chief Financial Officer of the Company, certify, pursuant to 18
      U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
      Act of 2002, that:





(1)
            The
                Report fully complies with the requirements of Section 13(a) or 15(d)
                of
                the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d));
                and





(2)
            The
                information contained in the Report fairly presents, in all material
                respects, the financial condition and results of operations of the
                Company.







/s/
                Michael GarnreiterMichael
                GarnreiterChief
                Financial Officer





Date:
      March 22, 2006
# GoToWebinar Attendee Report Notice of Proposed Rulemaking for Test Procedures Webinar Name 950563057 Webinar ID 

# General Information
3 Total Attended Mar 04, 2013 08:52 AM EST Actual Start Date/Time Actual Duration (minutes) 79 19 Clicked Registration Link 0 Opened Invitation Apr 01, 2013 10:55 AM PDT Generated



## Session Details McGonagle,Michael m.mcgonagle@ge.com

40225 Address State City Zip Code Country Phone Industry Organization GE Appliance Park, AP2-2C-61 Louisville KY US 502-452-5492 Manufacturing GE Appliances Unsubscribed No Mar 01, 2013 07:56 AM EST Registration Date

Yes Attended

In Session Interest Rating Attendee's In-Session Level of Interest: 80 Mar 04, 2013 08:56 AM EST Join Time 75.53 In Session Duration* (minutes) Mar 04, 2013 10:11 AM EST Leave Time Registration Q & A Questions Asked by Attendee Q: I dialed into the Webinar via telephone, but I cannot hear the audio of the meeting. A: --unanswered-- Poll Questions Post Session Survey Questions

*If an attendee left and rejoined the session, the In Session Duration column only includes their first visit.Reis,Callie callie.reis@navigant.com

01803 Address State City Zip Code Country Phone Industry Organization 77 South Bedford St. Burlington MA US 781-270-8326 Consulting Navigant Unsubscribed No Feb 11, 2013 12:15 PM EST Registration Date

Yes Attended

In Session Interest Rating Attendee's In-Session Level of Interest:33 Mar 04, 2013 09:05 AM EST Join Time 48.75 In Session Duration* (minutes) Mar 04, 2013 09:54 AM EST Leave Time Registration Q & A Questions Asked by Attendee Poll Questions Post Session Survey Questions Mouw,Nathan nathan_a_mouw@whirlpool.com

49022 Address State City Zip Code Country Phone Industry Organization 2000 N M63 benton harbor MI US Unsubscribed No Mar 04, 2013 09:06 AM EST Registration Date

Yes Attended

In Session Interest Rating Attendee's In-Session Level of Interest:54 Mar 04, 2013 09:10 AM EST Join Time 55.43 In Session Duration* (minutes) Mar 04, 2013 10:05 AM EST Leave Time Registration Q & A Questions Asked by Attendee Poll Questions Post Session Survey Questions

*If an attendee left and rejoined the session, the In Session Duration column only includes their first visit.James,Brian brian.james@sce.com

91702 Address State City Zip Code Country Phone Industry Organization 6042 N Irwindale Ave Ste B Irwindale CA US Energy, Chemical, Utilities Southern California Edison Unsubscribed No Mar 04, 2013 02:07 AM EST Registration Date

No Attended

In Session Interest Rating Attendee's In-Session Level of Interest: Join Time In Session Duration* (minutes) Leave Time Registration Q & A Questions Asked by Attendee Poll Questions Post Session Survey Questions

*If an attendee left and rejoined the session, the In Session Duration column only includes their first visit.
#### STATE ex rel. James Earl SPIKES v. Frank C. BLACKBURN, Warden.

No. 86-KH-1165.

Supreme Court of Louisiana.

June 27, 1986.

In re Spikes, James Earl; applying for writ of mandamus; Parish of Washington, 22nd Judicial District Court, Div. “C”.

Granted. The district court is ordered to act, if it has not already done so, on the post conviction petition submitted in April, 1986, if the petition has been filed.
III

106TH CONGRESS

1ST SESSION S. RES. 190

Designating the week of October 10, 1999, through October 16, 1999, as

National Cystic Fibrosis Awareness Week.

IN THE SENATE OF THE UNITED STATES

SEPTEMBER 29, 1999

Mr. CAMPBELL (for himself, Mr. GRAMM, Mr. ASHCROFT, Mr. KERRY, and

Mr. ROBB) submitted the following resolution; which was referred to the

Committee on the Judiciary

RESOLUTION

Designating the week of October 10, 1999, through October

16, 1999, as National Cystic Fibrosis Awareness Week.

Whereas Cystic Fibrosis is the most common fatal genetic

disease in the United States, for which there is no known

cure;

Whereas Cystic Fibrosis, characterized by digestive disorders

and chronic lung infections, has been linked to fatal lung

disease;

Whereas a total of more than 10,000,000 Americans are unknowing carriers of Cystic Fibrosis;

Whereas 1 out of every 3,900 babies in the United States are

born with Cystic Fibrosis;
2

•SRES 190 IS

Whereas approximately 30,000 people in the United States,

many of whom are children, suffer from Cystic Fibrosis;

Whereas the average life-expectancy of an individual with

Cystic Fibrosis is age 31;

Whereas prompt, aggressive treatment of the symptoms of

Cystic Fibrosis can extend the lives of those who suffer

with this disease;

Whereas recent advances in Cystic Fibrosis research have

produced promising leads in relation to gene, protein, and

drug therapies; and

Whereas education can help inform the public of Cystic Fibrosis symptoms, which will assist in early diagnoses, and

increase knowledge and understanding of this disease:

Now, therefore, be it

1 Resolved, that the Senate—

2 (1) designates the week of October 10, 1999,

3 through October 16, 1999, as National Cystic Fibro4 sis Awareness Week;

5 (2) commits to increasing the quality of life for

6 individuals with Cystic Fibrosis by promoting public

7 knowledge and understanding in a manner that will

8 result in earlier diagnoses, more fund raising efforts

9 for research, and increased levels of support for Cys10 tic Fibrosis sufferers and their families; and

11 (3) requests the President to issue a proclama12 tion calling on the people of the United States to ob-
3

•SRES 190 IS

1 serve the week with appropriate ceremonies and ac2 tivities.

Æ
Exhibit 99.1
 
 Certification Pursuant to 18 U.S.C. Section 1350,
 As Adopted Pursuant to Section 906 of the
 Sarbanes - Oxley Act of 2002
 
 In connection with the Annual Report of PLM Equipment Growth Fund IV Liquidating Trust (the "Trust"), on Form 10-KSB for the period from September 30, 2003 (inception) through December 31, 2003 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, the President of the Trustee and of the Trust, hereby certifies pursuant to 18 U.S.C. §1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:
 
 (1)  the Report of the Trust filed today fully complies with the requirements of Section 13(a) or 15 (d) of the Securities Exchange Act of 1934; and
 
 (2)  the information contained in the Report fairly presents, in all material respects, the net assets in liquidation and changes in net assets in liquidation of the Trust.
 
 
 
 
 /s/ James A. Coyne
 James A. Coyne
 President of PLM Financial Services, Inc.
 March 25, 2004
EXHIBIT 99(p)

                              Certifications


     This   certification   is   provided   pursuant   to  Section  906  of  the
Sarbanes-Oxley  Act of 2002 and  accompanies the annual report on Form 10-K (the
"Form  10-K")  for the year ended  December  31,  2002 of CRIIMI  MAE Inc.  (the
"Issuer").

     I, Barry S. Blattman,  Chief Executive Officer, certify that to the best of
my knowledge:

(i)      the Form 10-K fully complies with the requirements of Section 13(a) or
         Section 15(d) of the Securities Exchange Act of 1934
         (15 U.S.C. 78m(a) or 78o(d)); and

(ii)     the information contained in the Form 10-K fairly presents, in all
         material respects, the financial condition and results of operations
         of the Issuer.




March 28, 2003                         /s/Barry S. Blattman
---------------------------            -------------------------------------
DATE                                   Barry S. Blattman
                                       Chairman of the Board,
                                         Chief Executive Officer,
                                         and President
### IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

No. 19

- 30165

FIREFIGHTERS ’ RETIREMENT SYSTEM; MUNICIPAL EMPLOYEES RETIREMENT SYSTEM OF LOUISIANA; NEW ORLEANS FIREFIGHTERS ’ PENSION & RELIEF FUND,

Plaintiffs

- Appellants

v. CITCO GROUP LIMITED; CITCO FUND SERVICES (CAYMAN ISLANDS), LIMITED; CITCO BANKING C ORPORATION, N.V.,

Defendants

- Appellees

Appeal s from the United States District Court for the Middle District of Louisiana

Before WIENER, HIGGINSON, and HO, Circuit Judges

. JAMES C. HO, Circuit Judge : As this court recently reaffirmed, “t here is no final decision if a plaintiff voluntarily dismisses a defendant without prejudice, because the plaintiff ‘ is entitled to bring a later suit on the same cause of action. ’ ” Williams v. Taylor Seidenbach, Inc. , 958 F.3d 341, 343 (5th Cir. 2020) (en banc) (quoting Ryan v. Occidental Petroleum Corp. , 577 F.2d 298, 302 (5th Cir. 1978) ). We also observed that, under Rule 54(b), “in a suit against multiple defendants, there is no final decision as to one defendant until there is a final decision as to all defendants.” Id. United States Court of Appeals Fifth Circuit 

### FILED July 7, 2020 Lyle W. Cayce Clerk Case: 19-30165 Document: 00515479728 Page: 1 Date Filed: 07/07/2020No. 19

- 30165

2 Those principle s control this case. Here, a group of Louisiana pension funds sued various defendants for their alleged involvem ent in a Ponzi scheme. The district court later entered summary judgment for a set of defendants

— the Citco Group and various related entities. To appeal that decision , the Funds voluntarily dismissed one defendant without prejudice and then resolved all remaining claims either by settlement or default judgment. The only difference between this case and Williams is the order of dismissals after the adverse decision

. In Williams , the voluntary dismissal without prejudice disposed of all remaining defendants in the case

. 958 F.3d
at 344

. Here, the Funds voluntarily dismissed one defendant without prejudice and then adjudicated their claims against other defendants. But that is a distinction without a difference. T he Funds sought to render an int erlocutory decision appealable by dismissing at least one defendant without prejudice. And under Williams , that means

— absent some further act like a Rule 54(b) certification

— there is no final, appealable decision

. See id. at 34 3

. 1 We dismiss the appeal f or want of appellate jurisdiction.

1 Because the dismissal without prejudice in this case occurred after the order the Funds seek to appeal, we do not decide how Williams and Ryan would apply where the dismissal occurred before the adverse , interlocuto ry order. See Schoenfeld v. Babbitt , 168 F.3d 1257, 1265

– 66 (11th Cir. 1999) (concluding that there was a final decision in such a case). F or that reason, this decision does not create a split with the Eleventh Circuit

— and may explain why the Funds did not cite Schoenfeld in arguing that appellate jurisdiction exists here

. Case: 19-30165 Document: 00515479728 Page: 2 Date Filed: 07/07/2020
# Euroopa Liidu C 72I/2020

| | ISSN 1977-0898 |
| --- | --- |
| Euroopa Liidu
  Teataja | C 072I |
| | |
| Eestikeelne väljaanne | Teave ja teatised | 63. aastakäik5. märts 2020 |

ISSN 1977-0898

Euroopa Liidu

Teataja

C 072I

Eestikeelne väljaanne

Teave ja teatised

63. aastakäik5. märts 2020

---

| Sisukord | Lehekülg |
| --- | --- |
| | IV   Teave |
| | TEAVE EUROOPA LIIDU INSTITUTSIOONIDELT, ORGANITELT JA ASUTUSTELT |
| | Nõukogu |
| 2020/C 72 I/01 | Nõukogu Otsus, 27. veebruar 2020, millega nimetatakse ametisse Euroopa Liidu Intellektuaalomandi Ameti apellatsioonikoja esimees ja pikendatakse apellatsioonikoja esimehe ametiaega | 1 |

Sisukord

Lehekülg

IV   Teave

TEAVE EUROOPA LIIDU INSTITUTSIOONIDELT, ORGANITELT JA ASUTUSTELT

Nõukogu

2020/C 72 I/01

Nõukogu Otsus, 27. veebruar 2020, millega nimetatakse ametisse Euroopa Liidu Intellektuaalomandi Ameti apellatsioonikoja esimees ja pikendatakse apellatsioonikoja esimehe ametiaega

1

---

| ET | |
| --- | --- |

ET

---

IV Teave

TEAVE EUROOPA LIIDU INSTITUTSIOONIDELT, ORGANITELT JA ASUTUSTELT

Nõukogu

| 5.3.2020 | ET | Euroopa Liidu Teataja | CI 72/1 |
| --- | --- | --- | --- |

5.3.2020

ET

Euroopa Liidu Teataja

CI 72/1

---

NÕUKOGU OTSUS,

27. veebruar 2020,

millega nimetatakse ametisse Euroopa Liidu Intellektuaalomandi Ameti apellatsioonikoja esimees ja pikendatakse apellatsioonikoja esimehe ametiaega

(2020/C 72 I/01)

EUROOPA LIIDU NÕUKOGU,

võttes arvesse Euroopa Liidu toimimise lepingut,

võttes arvesse Euroopa Parlamendi ja nõukogu 14. juuni 2017. aasta määrust (EL) 2017/1001 Euroopa Liidu kaubamärgi kohta, (1) eriti selle artikli 166 lõikeid 1 ja 3,

ning arvestades järgmist:

| (1) | Euroopa Liidu Intellektuaalomandi Ameti (EUIPO) haldusnõukogu esitas 22. novembril 2019 nõukogule EUIPO apellatsioonikoja esimehe kandidaatide nimekirja. |
| --- | --- |

(1)

Euroopa Liidu Intellektuaalomandi Ameti (EUIPO) haldusnõukogu esitas 22. novembril 2019 nõukogule EUIPO apellatsioonikoja esimehe kandidaatide nimekirja.

| (2) | EUIPO haldusnõukogu otsustas 19. novembril 2019 teha nõukogule ettepaneku pikendada Detlef SCHENNENI ametiaega EUIPO apellatsioonikoja esimehena veel viieks aastaks alates 1. novembrist 2020, |
| --- | --- |

(2)

EUIPO haldusnõukogu otsustas 19. novembril 2019 teha nõukogule ettepaneku pikendada Detlef SCHENNENI ametiaega EUIPO apellatsioonikoja esimehena veel viieks aastaks alates 1. novembrist 2020,

ON VASTU VÕTNUD KÄESOLEVA OTSUSE:

Artikkel 1

1.   Virginia MELGAR, sündinud 19. juulil 1959 Minases (Uruguay), nimetatakse Euroopa Liidu Intellektuaalomandi Ameti (EUIPO) apellatsioonikoja esimeheks viieks aastaks.

2.   Kuupäeva, mil algab lõikes 1 osutatud viieaastane ametiaeg, määrab EUIPO haldusnõukogu.

Artikkel 2

Detlef SCHENNENI ametiaega EUIPO apellatsioonikoja esimehena pikendatakse 1. novembrist 2020 kuni 31. oktoobrini 2025.

Artikkel 3

Käesolev otsus jõustub selle Euroopa Liidu Teatajas avaldamise päeval.

Brüssel, 27. veebruar 2020

Nõukogu nimel

eesistuja

D. HORVAT

---

(1)  ELT L 154, 16.6.2017, lk 1.

1

---
Exhibit 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection  with the Annual Report of NYMAGIC,  INC. (the  "Company") on Form
10-K for the period ending  December 31, 2004 as filed with the  Securities  and
Exchange  Commission on the date hereof (the "Report"),  I, Thomas J. Iacopelli,
Chief Financial Officer of the Company,  certify,  pursuant to 18 U.S.C. Section
1350,  as adopted  pursuant  to Section 906 of the  Sarbanes-Oxley  Act of 2002,
that:

1.      The Report fully  complies  with the  requirements  of section  13(a) or
        15(d) of the Securities Exchange Act of 1934; and

2.      The information contained in the Report fairly presents, in all material
        respects,  the  financial  condition  and results of  operations  of the
        Company.


/s/ Thomas J. Iacopelli
-----------------------
Thomas J. Iacopelli
Chief Financial Officer
March 16, 2005
**Exhibit 32.2**

 

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350,**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with the Annual Report of SAFLINK Corporation (the “Company”) on Form 10-K/A for the period ended December 31, 2003, as filed withthe Securities and Exchange Commission on the date hereof (the “Report”), I, Jon C. Engman, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Actof 2002, that: 

 

(1) The Report fully complies with therequirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and 

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: April 29, 2004
SFBC INTERNATIONAL, INC






Exhibit 10.5

ANAPHARM, INC. 

2050, boul Rene-Levesque Ouest

Sainte-Foy (Quebec)

Canada G1V 2K8




May 19, 2005







Dr. Marc LeBel

2050, boul Rene-Levesque Ouest

Sainte-Foy (Quebec)

Canada G1V 2K8




Dear Dr. LeBel:




This letter agreement amends that certain employment agreement between you and Anapharm Inc. (the “Company”) dated March 18, 2002 (the “Employment Agreement”).




1.  Effective April 1, 2005, your annual salary set forth in Section 5(a) of the Employment Agreement shall be increased to CND $ 433,329 (which corresponds to $350,000 US dollars calculated as of May 9, 2005) paid in accordance with the Company’s usual payroll practices.  




2.  During the term of his employment, you shall be eligible to receive a Long-Term Incentive Award for each 12-month period beginning April 1, 2005 based upon three-year performance goals set  by the Compensation Committee.  




3.  Effective immediately, Section 6(e) of the Employment Agreement is replaced with the following:




(e)

Perquisites.  The Company shall pay or reimburse the Employee for up to $19,500 of expenses in any calendar year (or fiscal year if the Company’s parent elects to adopt a fiscal year for financial reporting purposes) related to perquisites or personal benefits not generally made available to all middle level employees provided that the Employee properly provides a written accounting of such expenses to the Company.  Expenses eligible for such payment or reimbursement include, but are not limited to the following:  automobile expenses, personal life and disability insurance premiums, unreimbursed medical expenses, travel costs of family members accompanying the Employee on business trips, and other expenses not generally available to middle level executives.  In addition, the Company shall pay the Employee an amount up to 35% of the cost of these perquisites up to the above maximum in order to reimburse the Employee for Canadian federal income taxes which may be incurred from these personal benefits.










Dr. Marc LeBel

May 19, 2005

Page 2 of 2











3.

The Company shall pay you a one-time retention bonus in the amount of $100,000.  The retention bonus will be paid upon execution of this Agreement, but shall vest quarterly over the 12 month period beginning April 1, 2005 and ending March 31, 2006.  If you cease to be employed by the Company for any reason during the 12 month period, any unvested portion of the signing bonus shall be forfeited and immediately repaid to the Company.  For example, if you cease to be employed by the Company before September 30, 2005, you shall repay $75,000 of the signing bonus to the Company.




We each acknowledge that in all other respects, the terms and conditions of the Employment Agreement remain in full force and effect.  Please indicate your agreement with the foregoing by signing below.  




Sincerely, 




Anapharm Inc.




By: _____________________

   

      David Natan

      Vice President

   

     







Acknowledged and agreed this

_____ day of May, 2005







______________________

Marc LeBel
EX-10.5





 EXHIBIT 10.5 

JOINT FILING AGREEMENT 
 The undersigned
acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of each of the undersigned without the
necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained herein and
therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that it knows or has reason to believe that such information is inaccurate. 

DATED: December 8, 2020 
 GENESIS PARK II LP 

By: Genesis Park II GP LLC, its general partner 
  

			
	By:	 	/s/ Paul W. Hobby
		 	Name: Paul W. Hobby
		 	Title: Authorized Signatory

 GENESIS PARK II GP LLC 
 By:
Genesis Park Holdco LP, its managing member 
 By: HSG GP LLC, its general partner 

 

			
		 	/s/ Paul W. Hobby
	By:	 	Name: Paul W. Hobby
		 	Title: Authorized Signatory